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ABSTRACT
Pityriasis Rosea is a self-limiting skin disorder of unknown etiology affecting women more than men. It is very rare in pregnancy and evidence 
shows conflicting reports on pregnancy outcomes related to Pityriasis Rosea. But recent evidence says, pregnancy outcomes are not altered, although 
clinicians must monitor the patient throughout the gestation for adverse outcomes. Hence, we report a case of Pityriasis Rosea infection in a 
primigravida, in the first trimester and the follow-up done in a tertiary care hospital in Southern India.
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INTRODUCTION
Pityriasis Rosea is a common self-limiting condition affecting the 
skin. It is usually acute and affects women more than men with higher 
incidences among young women. Etiology is unknown and can be 
due to viral or bacterial infection. It usually begins as a herald patch 
and slowly scaly oval shaped erythematous lesions evolve all over the 
trunk, limbs usually sparing the face and scalp. Prodromal symptoms 
include fatigue, malaise, fever, headache and sore throat. It is usually 
self-limiting and disappears after 4 weeks. Pharmacological treatment 
includes topical as well as oral steroids, antibiotics such as macrolides 
and antihistamines to control itching [1,2]. It is very rare in pregnancy, 
and only a few cases and studies have been done reporting the 
association of pregnancy with Pityriasis Rosea. Hence, we report a case 
of 27-year-old primigravida, diagnosed of Pityriasis Rosea at 12 weeks 
of gestation in a tertiary care hospital in Southern India.
CASE REPORT
Informed consent was taken from the patient. A 27-year-old female, 
primigravida, 12 weeks of gestation came with complaints of rashes all 
over her body for 7 days. Salmon colored scaly patches with peripheral 
collarette scaling were present all over the body sparing the face and scalp. 
1 week before the rashes appeared all over the body, a herald patch was 
noted in the left thigh. Systemic examination was normal, and vitals and 
blood pressure were stable. There was no associated fever and other signs 
of infection. There was no history of autoimmune disorders, no history 
of any drug intake during pregnancy. Partner was examined and he was 
found to be normal. Blood tests revealed elevated eosinophil counts and 
all the other routine blood investigations were normal. There was no 
itching and icterus was also absent. Pruritic urticarial papules and plaques 
of pregnancy were considered the first diagnosis but it usually affects 
women in the third trimester, and there was no associated pruritus. It was 
ruled out, and final diagnosis of Pityriasis Rosea was made as there were 
a herald patch and lesions involved the truck in Christmas tree pattern. 
The patient was treated with clobetasol cream 30/70 mixture for 2 weeks 
2 times daily and then for another 2 weeks once daily. Lesions subsided 
slowly in 2-3 weeks, and there was no recurrence. The patient now is in 
27 weeks of gestation and fetus is of normal growth, and anomaly scans 
were taken to rule out any fetal anomalies, and it was found to be normal. 
Both the mother and fetus are normal.
DISCUSSION
Pityriasis Rosea is very rarely reported in pregnancy and etiology is 
unknown. Human herpesvirus 6 and 7, Epstein Barr virus, parvovirus 
B19, and legionella pneumonia have been implicated as causative 
factors [3,4]. Placental barrier may sometimes become weaker due to 
damage and it may result in the transfer of infections from mother to 
fetus [5]. A study conducted among 38 pregnant females with Pityriasis 
Rosea reported 13% of women developed miscarriage before 15 weeks 
of gestation which is almost equal to miscarriages among general 
pregnancy population [6]. Furthermore, a literature search revealed in 
6 cases of pregnancy associated with Pityriasis Rosea, new born fetus 
had increased hypotonia and weak motility [6]. But recent research 
revealed Pityriasis Rosea during pregnancy has no adverse outcomes 
on the mother as well as fetus [7]. In our case, other conditions were 
ruled out which includes pruritic urticarial papules and plaques of 
pregnancy and history of drug allergy and intake of drugs known to 
cause skin disorders. The patient is still in 27 weeks of gestation, and 
there were no associated congenital abnormalities noted in the fetus as 
per anomaly scan reports.
CONCLUSION
Even though Pityriasis Rosea is a self-limiting condition, proper 
monitoring should be done if it is diagnosed during pregnancy. As 
there is no clear evidence on the adverse outcomes of Pityriasis 
Rosea on fetus, proper treatment with topical steroids should be 
given and proper investigations should be done to rule any congenital 
abnormalities. Furthermore, if Pityriasis Rosea is diagnosed during 
the first trimester of pregnancy, look for constitutional symptoms, 
and a proper dermatology opinion should be obtained. Further 
clinical studies can be done to find out the incidence of Pityriasis 
Rosea in pregnancy, and to evaluate its outcomes in pregnancy 
(Fig. 1).
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Fig. 1: Oval Slamon colored lesions in trunk
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